ArticleInternational journal of oncology2025

[Corrigendum] Dual targeting of glioblastoma multiforme with a proteasome inhibitor (Velcade) and a phosphatidylinositol 3‑kinase inhibitor (ZSTK474).

Lehang Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.